Phase I Clinical Study of GC012F Injection in Treatment of Refractory Systemic Lupus Erythematosus

计划入组 15 人 · 首次发布于 2023 年 5 月 6 日

Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies

计划入组 60 人 · 首次发布于 2025 年 1 月 6 日

COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo)

计划入组 60 人 · 首次发布于 2020 年 5 月 15 日

HD CD19 CAR-T

CD33 CAR-T

CD7 CAR-T cells

Mister Car Wash

United States

T-Knife GmbH

Germany

PH & T SpA

Italy

INOVIQ's CAR-NK Exosomes Demonstrate 61.5% Tumor Reduction in Triple-Negative Breast Cancer Study

PersonGen BioTherapeutics Wins 2026 Forbes China Industry Leading Enterprise Award for Breakthrough CAR-T Innovation

INOVIQ's CAR-Exosome Therapy Achieves 88% Cancer Cell Kill Rate in Preclinical Study